Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Last modified by pcoopman
Group name EquipePC
Item Type Journal Article
Title PKCtheta-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration
Creator Belguise et al.
Author K. Belguise
Author S. Cherradi
Author A. Sarr
Author F. Boissiere
Author N. Boulle
Author J. Simony-Lafontaine
Author V. Choesmel-Cadamuro
Author X. Wang
Author D. Chalbos
Abstract The AP-1 transcription factor Fra-1 is aberrantly expressed in a large number of cancers and plays crucial roles in cancer development and progression by stimulating the expression of genes involved in these processes. However, the control of Fra-1 transactivation ability is still unclear and here we hypothesized that PKCtheta-induced phosphorylation could be necessary to obtain a fully active Fra-1 protein. Using MCF7 stable cells overexpressing equivalent levels of unphosphorylated Fra-1 or PKCtheta-phosphorylated Fra-1, we showed that PKCtheta-induced phosphorylation of Fra-1 was crucial for the stimulation of MMP1 and IL6 expression. Consistently, we found a significant positive correlation between PRKCQ (coding for PKCtheta) and MMP1 mRNA expression levels in human breast cancer samples. PKCtheta-induced phosphorylations, in part at T217 and T227 residues, strongly and specifically increased Fra-1 transcriptional activity through the stimulation of Fra-1 transactivation domain, without affecting JUN factors. More importantly, these phosphorylations were required for Fra-1-induced migration of breast cancer cells and phosphorylated Fra-1 expression was enriched at the invasion front of human breast tumors. Taken together, our findings indicate that PKCtheta-induced phosphorylation could be important for the function of Fra-1 in cancer progression.
Publication Cancer Lett
Date Nov 2 2016
Journal Abbr Cancer letters
DOI 10.1016/j.canlet.2016.10.038
ISSN 1872-7980 (Electronic) 0304-3835 (Linking)
Tags first-last-corresponding, orig, original
Date Added 2018/11/14 - 12:07:50
Date Modified 2021/03/24 - 17:42:42
Notes and Attachments (Note)
(Note)
27816489 (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés